APPLICATION
NDA006920
TYPE
NDA
ORIGINAL APPROVAL
1949-08-16
LATEST ACTION
1979-04-17
ROUTE
ORAL
DOSAGE FORM
SUSPENSION, TABLET
MARKETING STATUS
Discontinued
Products
TRIPLE SULFASDiscontinued
TRISULFAPYRIMIDINES (SULFADIAZINE 167MG/5ML, SULFAMERAZINE 167MG/5ML, SULFAMETHAZINE) 167MG/5ML · SUSPENSION · ORAL
TRIPLE SULFASDiscontinued
TRISULFAPYRIMIDINES (SULFADIAZINE 167MG, SULFAMERAZINE 167MG, SULFAMETHAZINE) 167MG · TABLET · ORAL
Approval history
1979-04-17Manufacturing (CMC) · Supplement 9 · standardAP
1978-07-12Manufacturing (CMC) · Supplement 8 · standardAP
1977-12-22Manufacturing (CMC) · Supplement 7 · standardAP
1977-02-17Manufacturing (CMC) · Supplement 4 · standardAP
1949-08-16Type 5 - New Formulation or New Manufacturer · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.